AngioDynamics, Inc. cash flow to debt ratio of -99.82% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

AngioDynamics, Inc.'s free cash flow has increased -56.99% from $-33.93M last year to $-14.59M, signaling increasing performance

AngioDynamics, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

AngioDynamics, Inc.'s debt has decreased relative to shareholder equity from 0.02 last year to 0.00 today, signaling strengthened financials

AngioDynamics, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

AngioDynamics, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

AngioDynamics, Inc.'s profit margin has increased (-83.51%) in the last year from -60.66% to -10.00%, signaling increasing performance

AngioDynamics, Inc.'s short-term assets of $168.32M exceed its short-term liabilities of $76.20M

AngioDynamics, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

AngioDynamics, Inc.'s return on equity of -17.65%, is lower than 15.00%, indicating bad performance

AngioDynamics, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

AngioDynamics, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

AngioDynamics, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

AngioDynamics, Inc. has negative free cash flow, indicating cash burn

AngioDynamics, Inc.'s yearly earnings has increased -81.56% since last year from $-184.35M to $-33.99M, signaling increasing performance

AngioDynamics, Inc.'s yearly revenue has decreased -3.76% since last year from $303.91M to $292.50M, signaling decreasing performance

ROIC -13.03% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

AngioDynamics, Inc.'s 3-year revenue CAGR of -2.57% is negative, indicating declining revenue over the past 3 years

AngioDynamics, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

AngioDynamics, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

AngioDynamics, Inc. has insufficient data to evaluate this check.

AngioDynamics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

AngioDynamics, Inc. is overvalued relative to its fair value price of 1.65 based on EBITDA multiple model

AngioDynamics, Inc. has an EV/EBITDA ratio of 282.74x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

AngioDynamics, Inc. is overvalued relative to its fair value price of -9.72 based on Earnings Fair Value model

AngioDynamics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

AngioDynamics, Inc. has a price-to-book ratio of 3.12x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

AngioDynamics, Inc. has a price-to-sales ratio of 1.72x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue